| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | NKX2-3; NKX23; NKX2C; Homeobox protein Nkx-2.3; Homeobox protein NK-2 homolog C |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | A synthetic peptide corresponding to a sequence at the N-terminus of human NKX2-3. Human NKX2-3 shares 75% amino acid (aa) sequence identity with mouse NKX2-3. |
| Isotype | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-NKX2-3 Antibody catalog # A09210-1. Tested in IHC applications. This antibody reacts with Human.
Scientific background: This gene encodes a homeodomain-containing transcription factor. The encoded protein is a member of the NKX family of homeodomain transcription factors. Studies of similar proteins in mouse and rat have indicated a potential role in cellular differentiation.
Protein: Homeobox protein Nkx-2.3 | Gene: NK2 homeobox 3 | Target: NKX2-3
Host: Rabbit | Clonality/Clone: Polyclonal | Isotype: IgG | Reactivity: Human | Immunogen: A synthetic peptide corresponding to a sequence at the N-terminus of human NKX2-3. Human NKX2-3 shares 75% amino acid (aa) sequence identity with mouse NKX2-3. | Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml. | Purification: Immunogen affinity purified.
Applications: WB, IHC, ICC, ELISA
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
